Stock ATORX ALLIGATOR BIOSCIENCE AB
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Alligator Bioscience AB

Equities

ATORX

SE0000767188

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:44 2024-06-07 am EDT 		5-day change 1st Jan Change
1.156 SEK +1.40% Intraday chart for Alligator Bioscience AB +7.24% +67.78%
May. 23 Alligator Bioscience to Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO Annual Meeting CI
May. 21 US FDA Grants Investigational New Drug Clearance for Alligator Bioscience's Late-stage Gastric Cancer Treatment Trial MT

Evolution of the average Target Price on Alligator Bioscience AB

Price target over the last 5 years

History of analyst recommendation changes

c9d96b699c2ffb.rdohPaktaIzLTVYBa0UD75k6f4R--GyIqPDfoDQ5410.mYsWcvlqINq7YGFbI2hnqe5wM-wGrxm6zsTm9VhBtmXuikpe4x03uIkEGw~2ce45713cdc19cc3a62ba20812d54934

Analyst Recommendations on Alligator Bioscience AB

Alligator Bioscience's Pancreatic Cancer Combo Shows Improved Objective Response Rate in Mid-stage Study MT
Alligator Bioscience Announces Positive Interim Results from Mitazalimab Optimize-1 Phase 2 Trial in Pancreatic Cancer Exceeding 50% Objective Response Rate CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.156 SEK
Average target price
1.9 SEK
Spread / Average Target
+64.36%
High Price Target
2.3 SEK
Spread / Highest target
+98.96%
Low Price Target
1.1 SEK
Spread / Lowest Target
-4.84%

Consensus detail

Consensus revision (last 18 months)

Ratings for Alligator Bioscience AB

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ATORX Stock
  4. Consensus Alligator Bioscience AB